{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:36:13Z","timestamp":1760952973835,"version":"build-2065373602"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,19]]},"DOI":"10.7759\/cureus.94956","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:40:57Z","timestamp":1760942457000},"source":"Crossref","is-referenced-by-count":0,"title":["Common Hepatic Artery Resection and Reconstruction During Pancreaticoduodenectomy Following Chemotherapy for Locally-Advanced Pancreatic Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomohiro","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Iba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy T","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al.. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011, 364:1817-25. 10.1056\/NEJMoa1011923","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111945","article-title":"Conversion surgery for advanced pancreatic cancer","volume":"8","author":"Hank T","year":"2019","unstructured":"Hank T, Strobel O. Conversion surgery for advanced pancreatic cancer. J Clin Med. 2019, 8:1945. 10.3390\/jcm8111945","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-019-01804-x","article-title":"Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues","volume":"49","author":"Yoshitomi H","year":"2019","unstructured":"Yoshitomi H, Takano S, Furukawa K, Takayashiki T, Kuboki S, Ohtsuka M. Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues. Surg Today. 2019, 49:894-906. 10.1007\/s00595-019-01804-x","journal-title":"Surg Today"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31823ac299","article-title":"Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis","volume":"254","author":"Mollberg N","year":"2011","unstructured":"Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, B\u00fcchler MW, Weitz J. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011, 254:882-93. 10.1097\/SLA.0b013e31823ac299","journal-title":"Ann Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.04.005","article-title":"Arterial resections in pancreatic cancer - systematic review and meta-analysis","volume":"22","author":"Ma\u0142czak P","year":"2020","unstructured":"Ma\u0142czak P, Sier\u017c\u0119ga M, Stefura T, et al.. Arterial resections in pancreatic cancer - systematic review and meta-analysis. HPB (Oxford). 2020, 22:961-8. 10.1016\/j.hpb.2020.04.005","journal-title":"HPB (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2014.02.001","article-title":"Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)","volume":"155","author":"Bockhorn M","year":"2014","unstructured":"Bockhorn M, Uzunoglu FG, Adham M, et al.. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014, 155:977-88. 10.1016\/j.surg.2014.02.001","journal-title":"Surgery"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen S","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum B\u00fcschenfelde C, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010, 7:e1000267. 10.1371\/journal.pmed.1000267","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert T","year":"2016","unstructured":"Hackert T, Sachsenmaier M, Hinz U, et al.. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg. 2016, 264:457-63. 10.1097\/SLA.0000000000001850","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001049","article-title":"Nationwide multicenter observational study of FOLFIRINOX chemotherapy in 399 patients with unresectable or recurrent pancreatic cancer in Japan","volume":"47","author":"Todaka A","year":"2018","unstructured":"Todaka A, Mizuno N, Ozaka M, et al.. Nationwide multicenter observational study of FOLFIRINOX chemotherapy in 399 patients with unresectable or recurrent pancreatic cancer in Japan. Pancreas. 2018, 47:631-6. 10.1097\/MPA.0000000000001049","journal-title":"Pancreas"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24654","article-title":"Surgical strategies and novel therapies for locally advanced pancreatic cancer","volume":"116","author":"Abou-Khalil J","year":"2017","unstructured":"Abou-Khalil J, Rocha FG. Surgical strategies and novel therapies for locally advanced pancreatic cancer. J Surg Oncol. 2017, 116:16-24. 10.1002\/jso.24654","journal-title":"J Surg Oncol"},{"key":"ref11","article-title":"Hepatic artery reconstruction after extended resection for borderline resectable pancreatic head cancer: a case report","volume":"21","author":"Brasoveanu V","year":"2021","unstructured":"Brasoveanu V, Romanescu D, Diaconu C, et al.. Hepatic artery reconstruction after extended resection for borderline resectable pancreatic head cancer: a case report. Exp Ther Med. 2021, 21:87.","journal-title":"Exp Ther Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419452-common-hepatic-artery-resection-and-reconstruction-during-pancreaticoduodenectomy-following-chemotherapy-for-locally-advanced-pancreatic-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:40:58Z","timestamp":1760942458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419452-common-hepatic-artery-resection-and-reconstruction-during-pancreaticoduodenectomy-following-chemotherapy-for-locally-advanced-pancreatic-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.94956","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,19]]}}}